Tools

Hackett, G, Ramachandran, S, Strange, R and Jones, PW (2016) 004 Long Term Therapy With Testosterone Undecanoate in Type 2 Diabetes was Associated With Reduced All-Cause Mortality but no Significant Improvement in Conventional Risk Factors for CVD. The Journal of Sexual Medicine, 14 (1). S2 - S3. ISSN 1743-6095

[thumbnail of R Strange - Long term therapy with testosterone undecanoate in type 2 diabetes....pdf]
Preview
 Text
R Strange - Long term therapy with testosterone undecanoate in type 2 diabetes....pdf - Accepted Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.
Download (188kB) | Preview

Abstract

No abstract

Item Type: Article
Additional Information: Copyright © 2016 Published by Elsevier Inc
Subjects: R Medicine > RC Internal medicine > RC648 Diseases of the endocrine glands. Clinical endocrinology.
R Medicine > RC Internal medicine > RC660 Diabetes
Divisions: Faculty of Medicine and Health Sciences > Institute for Science and Technology in Medicine
Depositing User: Symplectic
Date Deposited: 10 Mar 2017 08:49
Last Modified: 12 Mar 2021 10:33
URI: https://eprints.keele.ac.uk/id/eprint/3010

Actions (login required)

View Item
View Item
Altmetric